Meta description: Vapotherm, Inc. shares traded at USD 2.17 on the NYSE, reflecting a slight decline. Investors review financial indicators and company fundamentals.
Company Overview
Vapotherm, Inc. is a medical technology enterprise specializing in respiratory care solutions. Founded in 1993 and headquartered in Exeter, New Hampshire, the company develops and commercializes proprietary high velocity therapy products across the United States and globally. Its technology primarily assists patients suffering from respiratory distress regardless of age group.
The product line includes Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox. These devices deliver heated, humidified and oxygenated air at high velocity via a small-bore nasal interface. Companion products include compressors, transfer units, aerosol adaptors, and tracheostomy accessories, aiding hospitals in managing varying levels of respiratory therapy needs.
Stock Performance
On the New York Stock Exchange, Vapotherm’s shares closed at USD 2.17, which marks a decline of USD 0.01 or 0.4587% over the previous session. Trading volume reached 28,038 shares, higher than the 19,707 average volume, suggesting moderate investor activity exceeding typical levels.
The 52-week price range is USD 0.6999 to USD 3.44, indicating significant variability in stock valuation during the period. The absence of a dividend signals that capital returns are currently focused on potential stock price appreciation rather than periodic shareholder payouts. The market capitalization stands at approximately USD 13.55 million, positioning Vapotherm in the micro-cap category, which commonly implies higher volatility and potential sensitivity to operational updates or market shifts.
Market Position and Sector
Vapotherm operates within the Medical – Devices industry in the Healthcare sector. This sector is characterized by innovation-driven growth coupled with regulatory oversight. Medical devices firms target both domestic and international hospital networks, requiring adaptable production and compliance with health authority standards.
Within this environment, companies like Vapotherm face competition from both large multinational corporations and smaller specialized producers. Sector trends include demand for non-invasive therapies, digital integration in medical devices, and expansion into emerging markets.
Governance and Leadership
Joseph F. Army CPA serves as Chief Executive Officer, steering the company’s strategic agenda. Effective leadership in medical devices often blends engineering insight with healthcare market knowledge. Under Mr. Army’s direction, Vapotherm focuses on product innovation for high velocity respiratory therapy and building relationships with hospital customers.
Corporate governance is essential for investor confidence, influencing resource allocation, regulatory compliance, and market communication.
Key Financial Data
Key indicators for Vapotherm for this session include:
- Share Price: USD 2.17
- Market Capitalization: USD 13,551,520
- Dividend: None declared
- 52-week Range: USD 0.6999 – USD 3.44
- Change: -0.01 (-0.4587%)
- Volume: 28,038 shares
- Average Volume: 19,707 shares
These figures indicate a small downward price movement in a session with above-average trading activity. For micro-cap stocks, volume spikes can signal investor reactions to news or shifts in sentiment.
FAQ
- Does Vapotherm pay dividends? No, the company currently offers no dividend to shareholders.
- On which exchange is Vapotherm listed? The company trades on the New York Stock Exchange under the ticker VAPO.
- How many employees does Vapotherm have? The company reports 182 full-time employees.
- What is Vapotherm’s primary industry? Medical devices, specifically respiratory therapy systems.
- What is the ISIN and CUSIP? ISIN: IE0003LFZ4U7, CUSIP: 922107107.
Conclusion
Vapotherm’s latest trading session saw a marginal decline in share price alongside elevated trading volume. Investors may watch price range dynamics and micro-cap volatility when assessing short-term moves. Longer-term positioning will depend on product adoption rates, sector demand factors, and financial performance.
Disclaimer
This article is for informational purposes only. It does not constitute investment advice or a solicitation to buy or sell securities.
Official Source
For full information about the company, see the link below.